Chapter 106. Antileukotrienes

  1. William W. Busse MD1 and
  2. Stephen T. Holgate BSc, MD, FRCP2
  1. Sven-Erik Dahlen

Published Online: 16 APR 2008

DOI: 10.1002/9780470694923.ch36

Asthma and Rhinitis, Second Edition

Asthma and Rhinitis, Second Edition

How to Cite

Dahlen, S.-E. (2000) Antileukotrienes, in Asthma and Rhinitis, Second Edition (eds W. W. Busse and S. T. Holgate), Blackwell Science Ltd, Oxford, UK. doi: 10.1002/9780470694923.ch36

Editor Information

  1. 1

    Professor of Medicine Head, Clinical Immunology, University of Wisconsin-Madison Medical School, Department of Medicine, Madison Wisconsin, USA

  2. 2

    Clinical Professor of Immuno-Pharmacology, Medical Specialties, Southampton General Hospital, Youthampton, UK

Publication History

  1. Published Online: 16 APR 2008
  2. Published Print: 1 JAN 2000

ISBN Information

Print ISBN: 9780632041756

Online ISBN: 9780470694923



  • antileukotrienes;
  • upper airways;
  • arachidonic acid;
  • asthma;
  • leukotriene cascade


This chapter contains section titled:

  • Introduction

  • Biosynthetic Pathway

  • Biological Activities and Receptors

  • Antileukotriene Drugs

  • Influence of Antiasthmatic Drugs on the Leukotriene Pathway

  • Leukotrienes as Mediators of Trigger-Factorevoked Airway Obstruction

  • Effects of Antileukotrienes in the Treatment of Asthma

  • Conclusions

  • Acknowledgements

  • References